WallStreetZenWallStreetZen

NASDAQ: TBIO
Telesis Bio Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

TBIO past revenue growth

How has TBIO's revenue growth performed historically?
Company
0.27%
Industry
9.25%
Market
17.15%
TBIO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TBIO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TBIO's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TBIO earnings and revenue history

Current Revenue
$27.5M
Current Earnings
-$49.0M
Current Profit Margin
-178.2%

TBIO Return on Equity

Current Company
-237.6%
Current Industry
10.5%
Current Market
188%
TBIO's Return on Equity (-237.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TBIO announces earnings.

TBIO Return on Assets

Current Company
-51.7%
Current Industry
5.3%
TBIO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TBIO Return on Capital Employed

Current Company
-71.67%
Current Industry
8.3%
TBIO has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TBIO vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TBIO$27.51M-$40.49M-$49.02M+54.68%N/A
NURO$5.90M-$6.47M-$6.53M-18.18%N/A
NXL$110.75k-$4.60M-$4.65M-81.64%N/A
VVOS$13.80M-$12.96M-$13.58M+29.48%N/A
HSCS$18.60k-$6.00M-$6.39M-14.04%N/A
View Top Medical Device Stocks

TBIO earnings dates

Next earnings date
May 10, 2024

Telesis Bio Earnings & Revenue FAQ

What were TBIO's earnings last quarter?

On Invalid Date, Telesis Bio (NASDAQ: TBIO) reported Q4 2023 earnings per share (EPS) of -$0.61, up 117.86% year over year. Total Telesis Bio earnings for the quarter were -$18.27 million. In the same quarter last year, Telesis Bio's earnings per share (EPS) was -$0.28.

If you're new to stock investing, here's how to buy Telesis Bio stock.

What was TBIO's earnings growth in the past year?

As of Q2 2024, Telesis Bio's earnings has grown year over year. Telesis Bio's earnings in the past year totalled -$49.02 million.

What is TBIO's earnings date?

Telesis Bio's earnings date is Invalid Date. Add TBIO to your watchlist to be reminded of TBIO's next earnings announcement.

What was TBIO's revenue last quarter?

On Invalid Date, Telesis Bio (NASDAQ: TBIO) reported Q4 2023 revenue of $6.98 million up 26.32% year over year. In the same quarter last year, Telesis Bio's revenue was $9.47 million.

What was TBIO's revenue growth in the past year?

As of Q2 2024, Telesis Bio's revenue has grown 0.27% year over year. This is 8.98 percentage points lower than the US Medical Devices industry revenue growth rate of 9.25%. Telesis Bio's revenue in the past year totalled $27.51 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.